- Medical - Diagnostics & Research
- Healthcare
Danaher Corporation
DHR · US ·
NYSE
273.91
USD
+3.82
(1.39%)
-
5.70
EPS
-
48.07
P/E
-
198B
MARKET CAP
-
0.38%
DIV YIELD
EPS Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 5.74 | 7.63 | 7.35 | 8.61 | 11.6 | 12.5 | 16.91% |
| Avg. Estimate | 5.49 | 7.57 | 6.98 | 8.05 | 11.1 | 12 | 16.91% |
| Low Estimate | 5.4 | 7.51 | 6.68 | 7.59 | 10.9 | 11.8 | 16.91% |
| No. Of Analysts | 13 | 17 | 14 | 7 | 2 | 4 |
Revenue Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 23.8B | 23.9B | 25.9B | 28.7B | 31.7B | 32.6B | 6.50% |
| Avg. Estimate | 23.6B | 23.8B | 25.7B | 27.7B | 30.6B | 31.5B | 5.98% |
| Low Estimate | 23.4B | 23.7B | 25.5B | 27.4B | 30.2B | 31.1B | 5.83% |
| No. Of Analysts | 12 | 16 | 18 | 17 | 8 | 8 |
Net Income Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 4.87B | 5.67B | 5.46B | 6.4B | 8.59B | 9.31B | 13.85% |
| Avg. Estimate | 4.06B | 5.63B | 5.12B | 5.86B | 8.22B | 8.9B | 17.03% |
| Low Estimate | 3.24B | 5.58B | 4.96B | 5.64B | 8.08B | 8.76B | 21.97% |
| No. Of Analysts | 12 | 16 | 18 | 17 | 8 | 8 |